BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 26045809)

  • 21. Overexpression of Long Non-Coding RNA NNT-AS1 Correlates with Tumor Progression and Poor Prognosis in Osteosarcoma.
    Ye H; Lin J; Yao X; Li Y; Lin X; Lu H
    Cell Physiol Biochem; 2018; 45(5):1904-1914. PubMed ID: 29518771
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MALAT1 predicts poor survival in osteosarcoma patients and promotes cell metastasis through associating with EZH2.
    Huo Y; Li Q; Wang X; Jiao X; Zheng J; Li Z; Pan X
    Oncotarget; 2017 Jul; 8(29):46993-47006. PubMed ID: 28388584
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Down-regulation of long non-coding RNA LET is associated with poor prognosis in gastric cancer.
    Zhou B; Jing XY; Wu JQ; Xi HF; Lu GJ
    Int J Clin Exp Pathol; 2014; 7(12):8893-8. PubMed ID: 25674261
    [TBL] [Abstract][Full Text] [Related]  

  • 24. LOXL1-AS1 predicts poor prognosis and promotes cell proliferation, migration, and invasion in osteosarcoma.
    Chen S; Li W; Guo A
    Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30944201
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Upregulation of long non-coding RNA TUG1 correlates with poor prognosis and disease status in osteosarcoma.
    Ma B; Li M; Zhang L; Huang M; Lei JB; Fu GH; Liu CX; Lai QW; Chen QQ; Wang YL
    Tumour Biol; 2016 Apr; 37(4):4445-55. PubMed ID: 26499949
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A long non-coding RNA contributes to doxorubicin resistance of osteosarcoma.
    Zhang CL; Zhu KP; Shen GQ; Zhu ZS
    Tumour Biol; 2016 Feb; 37(2):2737-48. PubMed ID: 26408180
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of lncRNA HULC in cervical cancer and its correlation with tumor progression and patient survival.
    Wang YF; Zhang S; Li XQ; Wang Y
    Eur Rev Med Pharmacol Sci; 2016 Oct; 20(19):3987-3991. PubMed ID: 27775802
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined over-expression of the hypoxia-inducible factor 2α gene and its long non-coding RNA predicts unfavorable prognosis of patients with osteosarcoma.
    Li W; He X; Xue R; Zhang Y; Zhang X; Lu J; Zhang Z; Xue L
    Pathol Res Pract; 2016 Oct; 212(10):861-866. PubMed ID: 27623205
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long non-coding RNA HULC as a novel serum biomarker for diagnosis and prognosis prediction of gastric cancer.
    Jin C; Shi W; Wang F; Shen X; Qi J; Cong H; Yuan J; Shi L; Zhu B; Luo X; Zhang Y; Ju S
    Oncotarget; 2016 Aug; 7(32):51763-51772. PubMed ID: 27322075
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LncRNA CBR3-AS1 predicts unfavorable prognosis and promotes tumorigenesis in osteosarcoma.
    Zhang Y; Meng W; Cui H
    Biomed Pharmacother; 2018 Jun; 102():169-174. PubMed ID: 29554595
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Up-regulation of long non-coding RNA BCAR4 predicts a poor prognosis in patients with osteosarcoma, and promotes cell invasion and metastasis.
    Ju L; Zhou YM; Yang GS
    Eur Rev Med Pharmacol Sci; 2016 Nov; 20(21):4445-4451. PubMed ID: 27874956
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decreased miR-134 expression and its tumor-suppressive function in human osteosarcoma.
    Bao Y; Peng L; Ma J; Liu K; Li W
    Genet Mol Res; 2015 Dec; 14(4):16771-81. PubMed ID: 26681023
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Upregulated expression of microRNA-214 is linked to tumor progression and adverse prognosis in pediatric osteosarcoma.
    Wang Z; Cai H; Lin L; Tang M; Cai H
    Pediatr Blood Cancer; 2014 Feb; 61(2):206-10. PubMed ID: 24038809
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long non-coding RNA tumor suppressor candidate 7 functions as a tumor suppressor and inhibits proliferation in osteosarcoma.
    Cong M; Li J; Jing R; Li Z
    Tumour Biol; 2016 Jul; 37(7):9441-50. PubMed ID: 26781978
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elevated long noncoding RNA HAGLROS expression correlates with clinical progression and prognosis in osteosarcoma.
    Wu PF; Dai ZT; Liu WD; Zhao ZX; Kong YH
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1428-1433. PubMed ID: 30840263
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MALAT1 promotes the proliferation and metastasis of osteosarcoma cells by activating the PI3K/Akt pathway.
    Dong Y; Liang G; Yuan B; Yang C; Gao R; Zhou X
    Tumour Biol; 2015 Mar; 36(3):1477-86. PubMed ID: 25431257
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The long non-coding RNA CCAT2 is up-regulated in ovarian cancer and associated with poor prognosis.
    Huang S; Qing C; Huang Z; Zhu Y
    Diagn Pathol; 2016 Jun; 11(1):49. PubMed ID: 27283598
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long Noncoding RNA Highly Up-regulated in Liver Cancer Predicts Unfavorable Outcome and Regulates Metastasis by MMPs in Triple-negative Breast Cancer.
    Shi F; Xiao F; Ding P; Qin H; Huang R
    Arch Med Res; 2016 Aug; 47(6):446-453. PubMed ID: 27986124
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long Noncoding RNA EWSAT1 Promotes Osteosarcoma Cell Growth and Metastasis Through Suppression of MEG3 Expression.
    Sun L; Yang C; Xu J; Feng Y; Wang L; Cui T
    DNA Cell Biol; 2016 Dec; 35(12):812-818. PubMed ID: 27860482
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long non-coding RNA CCAT2 is up-regulated in gastric cancer and associated with poor prognosis.
    Wang CY; Hua L; Yao KH; Chen JT; Zhang JJ; Hu JH
    Int J Clin Exp Pathol; 2015; 8(1):779-85. PubMed ID: 25755774
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.